세계 봉합 앵커 디바이스 시장은 예측 기간(2024-2031년) 동안 연평균 4.3%의 성장률을 보일 것으로 예상됩니다. 시장 성장의 주요 요인으로는 정형외과적 손상의 유병률 증가, 인대 및 기타 근골격계 구조와 관련된 문제를 해결하기 위한 시술에서의 사용 증가 등이 있습니다. 예를 들어, 2021년 12월 영국에서 발표된 Work-Related Musculoskeletal Disorders Statistics에 따르면, 2020/21년 4,70,000명의 근로자가 업무와 관련된 근골격계 질환(신규 또는 장기)을 앓고 있다고 합니다. 이는 근로자 10만 명당 1,420명에 해당하며, 전체 업무로 인한 건강상의 불건강의 28.0%를 차지합니다.
결찰 유형 중 매듭이 없는 봉합 앵커 하위 부문은 예측 기간 동안 성장할 것으로 예상됩니다. 이 부문을 주도하는 것은 정형외과 및 연조직 수술에서 최소 침습적 수술에 대한 추세가 증가함에 따라 매듭이 없는 봉합 앵커 디바이스에 대한 수요에 기여하고 있습니다. 매듭이 없는 봉합 앵커는 수술 중 매듭을 묶을 필요가 없어 수술 절차를 간소화하고 합병증 위험을 줄입니다. 2020년 9월, 의료 기술 기업 Smith+Nephew plc는 HEALICOIL(TM) KNOTLESS Suture Anchor를 출시하며 힘줄판 수복용 첨단 치유 솔루션의 혁신적인 제품 라인을 확장했습니다.
세계 봉합 앵커 디바이스 시장은 북미(미국, 캐나다), 유럽(영국, 이탈리아, 스페인, 독일, 프랑스, 기타 유럽 지역), 아시아태평양(인도, 중국, 일본, 한국, 기타 아시아 지역), 기타 지역(중동 및 아프리카, 라틴아메리카) 등 지역별로 더욱 세분화되어 있습니다. 그 중에서도 아시아태평양은 봉합 앵커 디바이스에 대한 수요 증가, 노인 인구 증가, 최소 침습 수술 증가, 정부 지원 정책, 유리한 의료 정책 등으로 인해 예측 기간 동안 성장할 것으로 예상되며, 아시아태평양의 봉합 앵커 디바이스 시장을 주도할 것으로 예상됩니다.
북미는 스포츠 관련 부상과 노화에 따른 정형외과 질환의 유병률 증가로 인해 봉합 앵커 디바이스 시장에서 큰 비중을 차지할 것으로 예상됩니다. Arthroscopy, Sports Medicine, and Rehabilitation 저널에 보고된 바와 같이, 2022년에 실시된 연구에 따르면, 선수의 21%가 무릎 구조적 손상을 경험했으며, 전체 손상률은 1,000경기 노출당 5.4명이었습니다. 연령별로는 20세 미만(3.2/1,000GE)이 가장 높았고, 30세 미만(3.1/1,000GE), 25-29세(3.0/1,000GE), 20-24세(2.3/100GE)의 순으로 나타났습니다. 경기당 플레이 시간별로는 30분 이상 플레이하는 비율이 가장 높았으며(3.9/1,000GE), 20.0-29.9분(3.0/1,000GE), 10.0-19.9분(1.8/1,000GE)의 순으로 나타났습니다. 이처럼 노령 인구의 증가는 정형외과 수술의 증가와 관련이 있으며, 이는 이 지역에서 조사된 시장을 견인하고 있습니다.
Global Suture Anchor Devices Market Size, Share & Trends Analysis Report by Material Type (Metallic Suture Anchor, Bio-Absorbable Suture Anchor, and Others), by Product (Absorbable, and Non-Absorbable), by Tying Type (Knotted Suture Anchors, and Knotless Suture Anchors), by End-Use (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2024-2031)
The global suture anchor devices market is anticipated to grow at a CAGR of 4.3% during the forecast period (2024-2031). Significant factors attributed to market growth includes increasing prevalence of orthopedic injuries, and growing use in procedures to address issues related to ligaments, and other musculoskeletal structures. For instance, iIn December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28.0% of all work-induced ill health.
The global suture anchor devices market is segmented on the by material type, product, tying type, and end-use. Based on the material type, the market is sub-segmented into metallic suture anchor, bio-absorbable suture anchor, and others. Others include polyetheretherketone (PEEK) suture anchor devices. Based on the product, the market is sub-segmented into absorbable, and non-absorbable. Based on the tying type, the market is sub-segmented into knotted suture anchors, and knotless suture anchors. Further, based on end-use, the market is sub-segmented into hospitals, clinics, and ambulatory surgical centers. Among the material type, the bio-absorbable suture anchor sub-segment is anticipated to hold a considerable share of the market, owing to the reducing the risk of adverse reactions, inflammation, or rejection, making them suitable for a wide range of patients.
Among the tying type, knotless suture anchors sub-segments expected to grow over the forecast period. The segment is driven by the growing trend towards minimally invasive procedures in orthopedic and soft tissue surgeries contributes to the demand for knotless suture anchor devices. Knotless suture anchors eliminate the need for tying knots during surgery, simplifying the procedure, and reducing the risk of complications, and are preferred by surgeons for their ease of use and potential for faster surgical times. Thus, the manufacturers are emphasizing on launching new products to cater to the demand in the market. In September 2020, Smith+Nephew plc, the medical technology business, launched the HEALICOIL™ KNOTLESS Suture Anchor, expanding its revolutionary line of advanced healing solutions for rotator cuff repair. This portfolio included the innovative REGENETEN™ Bioinductive Implant and novel REGENESORB™ Material. The open architecture design of the HEALICOIL KNOTLESS Suture Anchor coupled with REGENESORB Material was designed to facilitate a jump start in bone healing and formation.
The global suture anchor devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to grow over the forecast period, owing to the growing demand for suture anchor devices, increasing geriatric population, growing number of minimally invasive procedures, supportive government initiatives, and favorable healthcare policies, driving the suture anchor devices market in the Asia-Pacific.
North America is expected to hold a prominent share in the suture anchor devices market, owing to the increasing prevalence of sports-related injuries and age-related orthopedic conditions. As reported in the Arthroscopy, Sports Medicine, and Rehabilitation journal, a study conducted in 2022 revealed that 21% of players experienced structural knee injuries, with an overall injury rate of 5.4 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.2/1,000 GE) followed by less than 30 years old (3.1/1,000 GE), 25 to 29 years (3.0/1,000 GE), and 20 to 24 years (2.3/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.9/1,000 GE), followed by 20.0 to 29.9 minutes (3.0/1,000 GE), and 10.0 to 19.9 minutes (1.8/1,000 GE). Thus, an increasing geriatric population is associated with an increase in orthopedic surgeries, thus boosting the market studied in the region. In April 2022, Statistics Canada published the article "A portrait of Canada's growing population aged 85 and older from the 2021 Census", that there were 7.3 million people aged 65 and older in the country. Furthermore, over the next 25 years (by 2046), the population aged 85 and above may get triple to almost 2.5 million people.
The major companies serving the suture anchor devices market include Arthrex, Inc., ConMed Corp., Johnson and Johnson (DePuy Synthes, Inc.), Smith & Nephew plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, Stryker Corp., launched the Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system used Citregen™, a bioresorbable material designed to mimic the chemistry and structure of native bone.